The reliability of multi‐source data linkage for population‐based cancer survival estimates: A study in a metropolitan cancer registry of China

Author:

Shen Yubing1,Fu Ruiying1,Wang Xiaofeng2,Zhang Xinyu3,Zhou Ying4,Zhou Yiheng2,Liu Jue5,Mei Dan2,Han Bingfeng1,Li Li1,Wang Shaoming1,Chen Ru1,Sun Kexin1,Lin Hong2,Mu Huijuan6,Sun Ke2,Zeng Hongmei1,Wei Wenqiang1

Affiliation:

1. National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China

2. Dalian Center for Disease Control and Prevention Dalian Liaoning China

3. Academy of Mathematics and Systems Science Chinese Academy of Sciences Beijing China

4. Center for Smart and Healthy Buildings Huazhong University of Science and Technology Wuhan Hubei China

5. School of Public Health Peking University Beijing China

6. Liaoning Provincial Center for Disease Control and Prevention Shenyang Liaoning China

Abstract

AbstractBackgroundPopulation‐based cancer survival is a key metric in evaluating the overall effectiveness of health services and cancer control activities. Advancement in information technology enables accurate vital status tracking through multi‐source data linkage. However, its reliability for survival estimates in China is unclear.MethodsWe analyzed data from Dalian Cancer Registry to evaluate the reliability of multi‐source data linkage for population‐based cancer survival estimates in China. Newly diagnosed cancer patients in 2015 were included and followed until June 2021. We conducted single‐source data linkage by linking patients to Dalian Vital Statistics System, and multi‐source data linkage by further linking to Dalian Household Registration System and the hospital medical records. Patient vital status was subsequently determined through active follow‐up via telephone calls, referred to as comprehensive follow‐up, which served as the gold standard. Using the cohort method, we calculated 5‐year observed survival and age‐standardized relative survival for 20 cancer types and all cancers combined.ResultsCompared to comprehensive follow‐up, single‐source data linkage overestimated 5‐year observed survival by 3.2% for all cancers combined, ranging from 0.1% to 8.6% across 20 cancer types. Multi‐source data linkage provided a relatively complete patient vital status, with an observed survival estimate of only 0.3% higher for all cancers, ranging from 0% to 1.5% across 20 cancer types.ConclusionMulti‐source data linkage contributes to reliable population‐based cancer survival estimates in China. Linkage of multiple databases might be of great value in improving the efficiency of follow‐up and the quality of survival data for cancer patients in developing countries.

Publisher

Wiley

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3